Patrick Gaulé

Cette personne n’est plus à l’EPFL

À propos
Confidentialité
Mentions légales

Graph Chatbot

Publications associées (6)

Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases

Dominique Foray, Patrick Gaulé, Viviana Carolina Munoz Tellez de Kieffer, Fabiana Visentin

Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaboration ...

Oxford University Press2015

Product Development Partnerships for Neglected Diseases: Exploring a New Model of Pharmaceutical R&D

Dominique Foray, Patrick Gaulé, Viviana Carolina Munoz Tellez de Kieffer, Fabiana Visentin

Beech Tree Publishing2014

Is the US outperforming Europe in university technology licensing? A new perspective on the European Paradox

Annamaria Conti, Patrick Gaulé

Europe is perceived to be lagging behind the US in converting its academic results into economic outcomes. Using new survey data on European and US technology transfer offices (TTOs), we find that differences in academic research, TTO staff and experience ...

2011

Access to the scientific literature in India

Patrick Gaulé

This paper uses an evidence-based approach to assess the difficulties faced by developing country scientists in accessing the scientific literature. I compare backward citations patterns of Swiss and Indian scientists in a database of 43'150 scientific pap ...

2009

Three essays on access to knowledge

Patrick Gaulé

The first chapter of this thesis, coauthored with Annamaria Conti, seeks to add an economic contribution to the current debate on using university licensing contracts to improve access to medicines in developing countries. We build a simple model in which ...

EPFL2009

Access to vaccine technologies in developing countries: Brazil and India

Patrick Gaulé

This study, conducted by visits, interviews, and literature search, analyzes how vaccine manufacturers in Brazil and India access technologies for innovative vaccines: through collaborations with academia and research institutions, technology transfer agre ...

2007

Page 1 sur 1